Free press releases distribution network?

Agency / Source: Adfactors PR (P) Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



IBS Signs MoU with Government of Gujarat – Partners with Gujarat State Biotechnology Mission - IBS Centre for Bioinformatics to offer state-of-the-art research-based Biotechnology solutions towards modern medicine and therapy research
IBS Signs MoU with Government of Gujarat – Partners with Gujarat State Biotechnology Mission

 

PRZOOM - /newswire/ - Mumbai, Maharashtra, India, 2007/01/15 - IBS Centre for Bioinformatics to offer state-of-the-art research-based Biotechnology solutions towards modern medicine and therapy research.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Intelligent Business Systems (IBS) and Government of Gujarat have signed a Memorandum of Understanding (MoU) today to partner in Gujarat State Biotechnology Mission. Gujarat is the first state in India to set up a Biotechnology Solutions Venture which will be aimed at Research Outsourcing. As part of the MoU, Intelligent Business Systems Centre for Bioinformatics (CfB) along with Shanku’s Group will be providing the Bioinformatics & Biotechnology research based solutions respectively.

IBS will deal with computer-aided drug discovery, drug interaction and bio-analysis. Also, Shanku’s group will be investing Rs. 40 crore for the venture.

Speaking on the occasion, Dr. Kaustubh Chokshi, CEO and co-Founder, IBS, said, “Gujarat with its very strong Pharma, Healthcare and Agriculture sectors offers an ideal platform to venture into the emerging Biotechnology industry. IBS with its strong academic roots and research based approach to providing innovative solutions, is privileged to be part of this initiative to tap the growing opportunity that Biotechnology offers.”

He added, “At IBS we pioneer the use of novel and developmental bioinformatics research. IBS (intelligentsystems.biz) will offer cutting edge solutions to facilitate the goals of modern medicine and therapy research.”

Intelligent Business Systems’ CfB specialises in research and data analysis, which can be extended to provide an invaluable analytical insight into biological data and utilities to aid the scientific and commercial community in the understanding of genomic and proteomic data.

CfB will collaborate with academia on problems of relevance to improve medication and healthcare delivery. The mathematical approach has numerous cutting-edge applications in modern medicine and therapy development.
These include:

• Individuals responding adversely to one or more drugs;
• Predicting disease and treatment outcomes;
• Improved economic and practical efficiencies in healthcare delivery, thus better targeting high cost treatment to those patients most likely to benefit from it;
• Computationally complete genome sequence analysis and comparative genomics;
• Development of intelligent systems for genome;
• Protein interaction maps using gene fusion events;
• Pattern discovery;
• Evolution of the transcriptional machinery;
• Development of standards for genome sequence annotation;
• Document clustering and information extraction from biological text;
• Precocious diagnosis of life-threatening disease.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Adfactors PR (P) Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


IBS Signs MoU with Government of Gujarat – Partners with Gujarat State Biotechnology Mission

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Aniket Thakur - AdfactorsPR.com 
+91 98 92173022 aniket.thakur[.]adfactorspr.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Adfactors PR (P) Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Adfactors PR (P) Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Ipsen Announces Phase 3 CELESTIAL Trial of Cabozantinib Meets Primary Endpoint of Overall Survival
First Patient Treated with Microscopic Beads Pre-loaded with A Targeted Cancer Drug and Visible on CT Scans
BTG Plc Acquires Roxwood Medical
BTG and Mirada Medical Sign Three-Year Software Development Agreement
U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  BizJobs.com

Visit  RightITnow Ltd

Visit  SKS Media | SKS Associates Ltd







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today